NEW YORK (GenomeWeb News) – The University of Cincinnati will use Genedata’s data analysis software for high-throughput screening in its pharmaceutical studies program, the company said today.
Under the collaborative agreement, the Drug Discovery Center at the university's Genome Research Institute will use Genedata's Screener software for high-throughput and high-content screening research projects.
The company said that the software includes assay data management and analysis tools that are independent of tools, technology, volume, or location.
The DDC is developing molecular probes for use in pharmaceutical and biotechnology applications.
Financial terms of the agreement were not released.